AmeriCann Expands Team with VP of Sales and Business Development
Back to Newsroom
Mentioned in this Article

AmeriCann Expands Team with VP of Sales and Business Development

Thursday, March 28, 2019 8:30 AM
Share this article now
Company Update

Doug Carr Will Develop Relationships with Growers and Dispensaries for the Massachusetts Cannabis Center

DENVER, CO / ACESSWIRE / March 28, 2019 / AmeriCann, Inc. (OTCQB: ACAN), a cannabis company that is developing state-of-the-art cultivation, processing and product manufacturing facilities, announced Doug Carr will be the new Vice President of Sales and Business Development. Carr will develop strong business alliances and supply chain solutions for AmeriCann's developments throughout the country. Carr will focus initially on the Massachusetts market, developing relationships for AmeriCann Brands, the company's wholly owned consumer packaged goods (CPG) subsidiary.

AmeriCann Brands is securing licenses to manufacture both branded and white-label cannabis products including beverages, edibles, topicals, vape cartridges and concentrates. AmeriCann Brands will also provide extraction and product manufacturing support to AmeriCann's cultivation infrastructure, as well as to other independent licensed cannabis farmers. AmeriCann Brands plans to initially operate a Marijuana Product Manufacturing business, with over 40,000 square feet of state-of-the art extraction and product manufacturing infrastructure, at the Massachusetts Cannabis Center.

Carr brings more than 25 years of combined experience as a national manager in consumer packaged goods and commercial real estate. He worked for Fortune 500 companies, including RJ Reynolds/Nabisco, Inc. and General Mills, Inc., where he led national sales efforts launching new products to chains and buying groups. In addition to his considerable consumer products background, Carr has experience in commercial real estate acquisition, development and sales.

''I'm eager to join AmeriCann and lead business development efforts,'' says Carr. ''I have been a proponent of cannabis for many years, and I admire the work that AmeriCann is doing in Massachusetts to produce consistent and sustainable products. I look forward to building business relationships across the Commonwealth, and the country, in this new role.''

Carr, a New England native and alumnus of the University of Massachusetts Amherst, has been involved in the cannabis industry as a consultant and investor since 2013. As a stage 4 cancer survivor, Carr also helps educate patients and doctors on the benefits of cannabis-based products.

''With the rapid growth of the Massachusetts market and our progress on the Massachusetts Cannabis Center, we felt it was the perfect time to add Doug and his experience to our team,'' says Tim Keogh, CEO of AmeriCann. ''Doug's background in consumer products plus his personal and professional background in the cannabis industry make him a great addition.''

The Massachusetts Cannabis Center is being developed on a 52-acre parcel located in Southeastern Massachusetts. The MCC project is permitted for 987,000 sq. ft. of cannabis cultivation and processing infrastructure, which will be developed in phases to support both the existing medical cannabis and the newly emerging adult-use cannabis marketplace.

AmeriCann plans to replicate the brands, technology and innovations developed at its MCC project to new markets as a licensed multi-state operator (MSO).

About AmeriCann
AmeriCann (OTCQB: ACAN) is a cannabis company that is developing cultivation, processing and product manufacturing facilities.

AmeriCann uses greenhouse technology for cannabis cultivation and is designing GMP Certified cannabis extraction and product manufacturing infrastructure.

More information about the Company is available at:, or follow AmeriCann at @ACANinfo on Twitter, @AmeriCann on Facebook, @AmeriCannInc on Instagram, AmeriCann, Inc on LinkedIn.

About Massachusetts Cannabis Center
The Massachusetts Cannabis Center (MCC), is a one million square foot sustainable greenhouse facility in Freetown, Mass which is being developed by AmeriCann. The first phase of the facility is scheduled to open and be ready for cannabis cultivation, processing, and infused product production in the summer of 2019. Once fully developed, the MCC design calls for a research facility, a training center, corporate offices, a quality-assurance laboratory, and a facility for manufacturing cannabis-infused food, nutraceuticals and consumer packaged cannabis goods.

AmeriCann plans to replicate the brands, technology and innovations developed at its MCC project to new markets as a licensed multi-state operator (MSO).

Forward-Looking Statements
This press release contains ''forward-looking statements'' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the ''Exchange Act'') (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words ''believe,'' ''anticipate,'' ''estimate,'' ''expect,'' ''intend,'' ''plan,'' ''project,'' ''prospects,'' ''outlook,'' and similar words or expressions, or future or conditional verbs such as ''will,'' ''should,'' ''would,'' ''may,'' and ''could'' are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional uncertainties that could impact the Company's forward-looking statements, please see the Company's Registration Statement on Form S-1, which the Company recently filed with the SEC and which may be viewed at

Contact Information:

Corporate and Investors:
AmeriCann, Inc.
1550 Wewatta Street
2nd Floor
Denver, CO 80202
(303) 862-9000
[email protected]
@ACANinfo on Twitter
@AmeriCann on Facebook
@AmeriCannInc on Instagram
AmeriCann, Inc on LinkedIn

Teak Media + Communication
Sarah Gledhill
[email protected]
(617) 269-7171

SOURCE: AmeriCann, Inc.

AmeriCann, Inc.
Back to Newsroom
Copyright 2021 © ACCESSWIRE. All rights reserved. Privacy Policy  |   Terms and Conditions